Patient-Derived Non-Muscular Invasive Bladder Cancer Xenografts of Main Molecular Subtypes of the Tumor for Anti-Pd-l1 Treatment Assessment
Екатерина Блинова(Sechenov University), А. Д. Каприн(Peoples' Friendship University of Russia), Pavel Zhdanov, M.V. Nelipa(Sechenov University), Т. А. Демура(Sechenov University), Evgenya A. Kogan(Sechenov University), Elena Samishina, Д А Рощин, И. Р. Суслова, Y. I. Osmanov(Sechenov University), O. N. Deryabina(National Research Mordovia State University), Д. С. Блинов(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology)
Cited by 19
Related Papers
Therapeutic Potential and Main Methods of Obtaining Selenium Nanoparticles
|International Journal of Molecular Sciences|2021|85
Nuclear nanomedicine using Si nanoparticles as safe and effective carriers of 188Re radionuclide for cancer therapy
|Scientific Reports|2019|67
Novel Hydroxypyridine Compound Protects Brain Cells against Ischemic Damage In Vitro and In Vivo
|International Journal of Molecular Sciences|2022|16
Novel aminochromone derivative inhibits tumor growth on xenograft model of lung cancer in mice
|Journal of Advanced Pharmaceutical Technology amp Research|2018|14
Internal doses in experimental mice and rats following exposure to neutron-activated 56MnO2 powder: results of an international, multicenter study
|Radiation and Environmental Biophysics|2020|14